000 | 01765 a2200505 4500 | ||
---|---|---|---|
005 | 20250514165320.0 | ||
264 | 0 | _c20040914 | |
008 | 200409s 0 0 eng d | ||
022 | _a0085-2538 | ||
024 | 7 |
_a10.1111/j.1523-1755.2004.00429.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRao, Madhumathi | |
245 | 0 | 0 |
_aDialyzer membrane type and reuse practice influence polymorphonuclear leukocyte function in hemodialysis patients. _h[electronic resource] |
260 |
_bKidney international _cFeb 2004 |
||
300 |
_a682-91 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aCarcinogens _xpharmacology |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 | _aComorbidity |
650 | 0 | 4 | _aCross-Sectional Studies |
650 | 0 | 4 | _aEquipment Reuse |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKidney Failure, Chronic _xepidemiology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMembranes, Artificial |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aN-Formylmethionine Leucyl-Phenylalanine _xpharmacology |
650 | 0 | 4 |
_aNeutrophils _xdrug effects |
650 | 0 | 4 | _aPhagocytosis |
650 | 0 | 4 |
_aRenal Dialysis _xinstrumentation |
650 | 0 | 4 | _aRespiratory Burst |
650 | 0 | 4 |
_aSuperoxides _xmetabolism |
650 | 0 | 4 |
_aTetradecanoylphorbol Acetate _xpharmacology |
700 | 1 | _aGuo, Daqing | |
700 | 1 | _aJaber, Bertrand L | |
700 | 1 | _aSundaram, Sumuk | |
700 | 1 | _aCendoroglo, Miguel | |
700 | 1 | _aKing, Andrew J | |
700 | 1 | _aPereira, Brian J G | |
700 | 1 | _aBalakrishnan, Vaidyanathapuram S | |
773 | 0 |
_tKidney international _gvol. 65 _gno. 2 _gp. 682-91 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1523-1755.2004.00429.x _zAvailable from publisher's website |
999 |
_c14446276 _d14446276 |